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Summary.-Following a single injection of MNU into " intact " mice, a high incidence
of leukaemia (900o) is obtained, with a 500% induction time of 200 days. Immuno-
logical studies indicate that the 0 antigen is expressed on the leukaemic cells.
Thymectomized MNU treated mice had a 50%o induction time of 500 days, and the
incidence was somewhat lower. Leukaemias failed to develop in MNU treated
T lymphocyte deficient animals and in lethally irradiated, or thymectomized lethally
irradiated mice reconstituted with MNU treated bone marrow. It is suggested that
the T lymphocytes rather than the haemopoietic stem cells or pre-T cells are the
" target cells" in MNU leukaemogenesis.
IN AN IMPORTANT paper recently,
Haran-Ghera and Peled (1973) found that
dimethylbenz(a)anthracene (DMBA) will
produce specifically B lymphocyte leukae-
mia in several mouse strains tested,
whereas radiation and virus produce
T lymphocyte leukaemias. Subsequently,
it was shown (Haran-Ghera, 1973) that
transplant of bone marrow, 80 days after
DMBA treatment, into syngeneic mice
resulted in a 100% incidence of leukaemia
in the recipients within 20 days. Here
we describe another chemically (methyl-
nitrosourea) induced leukaemia which
shows some essential differences from the
DMBA induced B lymphocyte leukaemia.
MATERIALS AND METHODS
Mice.-Female BDF1 (C57B1 x DBA/2
FI) mice, 8-10 weeks old were used. Thy-
mectomy (Kaplan, 1950) or splenectomy
(Schofield and Cole, 1968) was performed
when the animals were 4-6 weeks old.
Experimental animals were kept 3 to a cage
and supplied with food and water ad libitum.
Irradiation.-X-rays were produced by a
Siemens Stabilipan x-ray machine operating
at 300 kVp and 12 mA, with a half value
layer of2 mm Cu. Dose rate was 30 rad/min.
Chemicals.-The nitrosamide, methyl-
nitrosourea (MNU) was chosen for the
chemical induction of leukaemia. It is a
highly effective carcinogen and can induce
a wide variety of tumours (Druckrey et al.,
1961, 1964) including lymphomata in mice
after a single injection (Joshi and Frei, 1970a,
b). MNU was synthesized in these labora-
tories by Dr A. W. Craig and stored as a
crystalline solid at -20°C. For experi-
mental use MNU was dissolved in ice-cold
physiological saline and the solution sterilized
by passage through a millipore filter, pore-size
0*22 1um. This solution was then injected
into one of the lateral tail veins of unanaes-
thetized mice. MNU solution was always
made up freshly at a concentration of2 mg/ml
andusedwithin5 min ofitsdissolving. When
the change in optical density at 230 nm was
followed, in a cell maintained at 4°C by pas-
sing iced water through thermospacers, it
was found that less than 10% of the com-
pound had decomposed within the first 10
min. It has previously been shown (Druck-
rey et al., 1967) that MNU has a short half-
life in vivo and, in contrast with the nitro-
samines, needs no enzyme activation.
Pathology of leukaemias.-Animals sus-
pected of having leukaemia were killed and
various tissues were taken for histological
examination, including peripheral lymph
nodes (superficial cervical, axillary, brachial,
mesenteric and inguinal), thymus, spleen and
liver, and occasionally bone marrow. Other
organs were taken only if grossly involved.
In the majority of instances, the malig-
nancy of the cells was estimated by re-T. M. DEXTER, R. SCHOFIELD, L. G. LAJTHA AND M. MOORE
transplantation studies; 5 x 105-107 spleen,
bone marrow or thymus cells were injected
intravenously into three 8-10 week old
BDFL mice. The latent period and gross
pathology of any resulting leukaemias were
recorded.
T lymphocyte deficient animals.-These
were obtained by thymectomy at 4-6 weeks
of age, followed 2 weeks later by potentially
lethal irradiation (850 rad x-rays) and
immediate reconstitution with a graft of 106
syngeneic bone marrow cells. In such
animals T lymphocytes are numerically few,
but normal numbers of B lymphocytes are
found (Miller and Mitchell, 1969).
RESULTS
Induction of leukaemia in "intact ",
splenectomized, thymectomized and T
lymphocyte deficient mice
The leukaemogenic effect of a single
intravenous injection of 50 mgfkg MNU
is shown in Table I. Over an observation
period of 500 days, no mice in the control
groups developed leukaemia. MNU-
treated " intact " and splenectomized
animals show a similar leukaemia incid-
ence, with 50% incidence induction times
of 200 and 190 days respectively.
Thymectomized mice, however, have a
reduced incidence of leukaemia, with a
greatly extended latent period. T lympho-
cyte deficient animals failed to develop
leukaemia following treatment with MNU
(Table I, Group B).
Induction of leukaemia in potentially
lethally irradiated or T lymphocyte
deficient mice receiving grafts of MNU
treated haemopoietic cells
In the first experiment 25 " intact"
mice were treated with 50 mgfkg MNU.
Twenty-four h later the animals were
killed and the femoral marrow collected
and diluted in Fischer's medium so that
approximately 150 CFUs (spleen colony
forming units: Till and McCulloch, 1961)
were contained in 0 25 ml of dilution
fluid. This volume of bone marrow
suspension was then injected into mice
irradiated with 850 rad x-rays 2 h pre-
viously. Each recipient received marrow
cells from only one donor. During an
observation period of 340 days, no experi-
mental animals developed leukaemia
(Table I, Group C1).
In a second experiment, 25 " intact"
mice were treated as above. Seventy days
later the femoral and tibial marrow was
removed and injected into potentially
lethally irradiated (850 rad x-rays) synge-
neic mice of comparable ages. Each
recipient was reconstituted with bone
marrow cells from only one donor, and
received a graft of marrow containing
approximately 4500 CFUs. Over anobser-
vation period of 180 days (i.e. 250 days
post MMU treatment) no mice had
developed leukaemia (Table I, Group C1).
In a further experiment, " intact "
TABLE I.-Induction ofLeukaemia by MNU
Group
A 1 Intact controls (saline injected)
2 Thymectomized controls (saline injected)
B 1 Intact (50 mg/kg MNU)
2 Splenectomized (50 mg/kg MNU)
3 Thymectomized (50 mg/kg MNU)
4 T lymphocyte deficient (50 mg/kg MNU)
C 1 850 rad TBR* + bone marrow treated with
MNU in vivo (24 h)
(70 days)
2 Thymectomy + 850 rad TBR* + MNU
treated bone marrow (150 CFUs)
D Intact (50 mg/kg MNU + 500 rad TBR
x-rays + normal bone marrow and thymus
cells
Observation
period (days)
500
500
500
500
600
450
Leukaemia
incidence
0/40
0/25
45/50
22/25
17/25
0/15
50% induction
(o%) time (days)
0
0
(90)
(88)
(68)
(0)
200
190
500
340 0/25 (0)
250 (180)t 0/25 (0)
450
300
1/15 (6.6)
0/25 (0)
* = 850 rad x-rays, total body radiation.
t i.e. 180 days after grafting of bone marrow from mice treated 70 days previously with MNU.
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animals were injected with 50 mg/kg
MNU and the femoral bone marrow
separately collected from each mouse 24 h
later, as de3cribed above; 0. 25 ml of
bone marrow suspension (containing
approximately 150 CFUs) was then
injected into thymectomized animals,
irradiated with 850 rad x-rays 2 h pre-
viously (the marrow from each donor
being used to reconstitute only one reci-
pient). In this group one animal out of
15 developed leukaemia (Table I, Group
C2) presenting as hepatomegaly.
"Host effect " in MNIU leukaemogenesis
The possibility that the leukaemogenic
activity is a secondary manifestation of a
primary effect on host tissues other than
those producing haemopoietic cells, was
tested in the following way: " Intact "
mice were treated with 50 mg/kg MNU,
followed 24 h later by 500 rad x-rays
(with this combination of treatments the
additive cytotoxic effects are such that
no animals survive without marrow graft-
ing). Immediately after x-irradiation the
animals received a graft of 2 x 106
untreated bone marrow cells (containing
approximately 600 CFUs) and a subcu-
taneous implant (axillary region) of thy-
mus from syngeneic mice of the same age.
Out of a group of 25 mice, no animals
developed leukaemia (Table ID).
Pathology and transplantability of MNU
induced leukaemia
Histological findings are shown in
Table II. The majority of leukaemias
arising in MNU treated " intact " animals
involved both thymus and spleen. In
185 of animals, however, no thymus
involvement was seen. In thymecto-
mized animals, however, spleen and liver
were involved in all cases, and the mesen-
teric lymph node in 40% of the mice.
Other lymph nodes were not involved.
In all 3 groups, leukaemic cells were of
the undifferentiated blast cell type. No
evidence of differentiation along a parti-
cularmorphological pathwaywasobserved.
Transplantation of MNU induced leu-
kaemias, arising in " intact " and splenec-
tomized mice, into unirradiated adult
syngeneic recipients was always successful.
The latent periods between inoculation
and death of the first transplant varied
from 14 to 56 days, but on subsequent
transfers stabilized at 10-14 days. All
transplanted leukaemias were character-
ised by massive hepatosplenomegaly and
consisted of undifferentiated blast cells.
Transplantation of leukaemias arising in
thymectomized mice was more difficult.
Although morphologically the leukaemic
cells were indistinguishable, successful
transplantations were achieved only from
animals presenting with simply liver and
spleen involvement. In those animals
TABLE II.-Distribution of Leukaemic Involvemont in Various Tissues after a
Single Injection of 50 mg/kg MNU
% of animals showing involvement
Splenectomized
84
36
8
12
12
12
12
Thymectomized
*
100
100
0
0
0
40
0
* Remants of thymus tissue were carefully looked for at time ofautopsy.
In only one case was thymus tissue observed and this mouse was not
included in the results.
Tissue
Thymus
Spleen
Liver
Lymph nodes
Cervical
Axillary
Brachial
Mesenteric
Inguinal
Intact
82
80
36
30
28
24
18
18
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where the mesenteric lymph node was
also involved, the leukaemic cells were
not transplantable.
Cell surface markers in MNU induced
leukaemias
A preliminary survey of leukaemic
cells for surface markers associated with
B and T lymphocytes was undertaken.
Primary MNU leukaemias were tested
for the presence ofsurface immunoglobulin
(Ig) determinants, characteristic of bone
marrow derived, thymus independent
lymphocytes, by the direct immuno-
fluorescence technique (Raff, Sternberg
and Taylor, 1970) using fluoresceinated
anti-mouse Ig (diluted 1: 4 with PBS).
The results were compared with the
fluorescent staining properties of cells
derived from normal mouse lymphoid
tissues. The percentage staining of lym-
phoid cells originating from normal spleen
was 40 4 (Table III), the reactive cells
revealing typical defined fluorescent
" capping " ofthe cell surface. No stained
cells were identified in normal thymocyte
preparations, and insignificant numbers
in leukaemic thymus preparations (Table
III, Groups A, B, C). By contrast, the
degree of staining of splenic lymphocytes
from leukaemias arising in " intact " mice
depended upon the extent to which
leukaemic disease involved the organ.
Thus, in those cases where the thymus
and spleen were grossly involved (gross
enlargement confirmed by microscopical
examination) the proportion of Ig bearing
cells in the spleen was 3.000 (Group A).
By contrast, in one mouse where the
spleen showed only a modest degree of
leukaemic involvement (microscopical
examination), the number of Ig bearing
cells was intermediate between that of the
grossly involved and disease-free organs
(Group B). In those cases, however,
where the leukaemia was microscopically
confined to the thymus the number of Ig
bearing cells (46-70%) fell within the nor-
mal range (Group C). In thymectomized
control mice (assayed 450 days post
thymectomy) the proportion of Ig stain-
ing cells in spleen was increased to 5300.
However, in 2 leukaemias arising in thy-
mectomized mice, the proportion of Ig
bearing cells was less than 1%. These
data indicate that MNU leukaemias arising
in " intact " or thymectomized mice are
not associated with B lymphocytes.
TABLE III. Expression of 0 Antigen and Ig Determinants on the CellSurface of Normal
Mouse Lymphoid Tissues and MATU Induced Leukaernias
Anti-0 cytotoxicity
indices Ig bearing cells
Spleen Thymus Spleen Thymus
Mean Mean Mlean Mean
Group (range) (range) (range) (range)
"Intact" control 27 -3(25*9-29*0) 87 2 (84-90) 40 4(35*6-44*2) 0
i;T- 4. 1 ' Intact i leukaemias
A. (6 mice)
B. (1 mouse)
C. (3 mice)
D. (5 mice)
Thymectomy control
" Thymectomy " leuka,emias
5-9* 4 (46-73) I3 - 5 (73 * 5-73* 6)
ND
ND
93 (2-2-13-2)
ot
53* I (1 mouse)
ND
53 3 (48-58- 3)
ND
3 0(0 1-13.7)
16-8
46-7 (1 mouse)
0 7 (0 1-3 1)
53- 2 (525- 5-53- 8)
0 9 (0 8-1 0)
(2 mice)
0-2
(0-0 6)
1-1
(1 1
(0-0 * 1)
ND
t 450 days post-thymectomy; ND = not determined.
A. Spleen and thymus both showing gross leukaemic involvement.
B. Thymus grossly leukaemic. Spleen marginally infiltrated (microscopic examination).
C. Thymus only, showing leukaemic involvement. Spleen " normal ", i.e. no leukaemic infiltration.
D. Spleen involved, no thymus involvement.
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The primary MNU induced leukaemias
were tested also for the presence of 0
antigen in a cytotoxicity assay based on
release of chromium 51 (Wigzell, 1965)
using AKR anti-OC3H serum prepared
by the method of Reif and Allen (1964)
and guinea-pig serum absorbed with
agarose as a source of complement. All
tests were performed in quadruplicate and
the average number of counts released
per tube with 0 antiserum, normal mouse
serum and with the detergent triton, was
calculated (Raff and Wortis, 1970) and a
cytotoxic index determined for each cell
type according to the formula:
counts released (CR) with antiserum -
CR with NMS
CR with triton - CR, with NMS
The cytotoxic indices for 6 mice
(Table III, Group A) where leukaemic
disease involved the thymus and the spleen
ranged from 73-500 in the thymus to
59.4/ in the spleen. Whilst the indices
for leukaemic thymocytes were somewhat
less than that obtained for normal thymus
preparations, the indices for leukaemic
spleen cells were significantly higher,
indicating that the leukaemias express 0
antigen. In leukaemias showing only
thymus involvement (Group C) a fairly
high cytotoxic index is maintained for the
leukaemicthymocytes. Inthose micewhere
the leukaemia involved the spleen, and not
the thymus, uniformly low anti-0 cytotoxic
indices were found for leukaemic spleen
cells. This occurs concomitantly with a
virtual lack ofIg bearing cells (Group D).
In control thymectomized mice, spleen
cells were 0 antigen negative whilst, in
an isolated example, splenic lymphocytes
from a leukaemic thymectomized mouse
were 0 antigen positive, indicating here
that the leukaemic cells were T lym-
phocytes.
DISCUSSION
The high incidence of leukaemia seen
in " intact " mice after MNU is com-
parable with results published by other
authors (Joshi and Frei, 1970a, b), who
observed a 72% incidence of malignant
lymphoma in CFW/D mice after a single
i.p. injection of MNU. In all these
experiments a majority of leukaemias
showed involvement of the thymus and
infiltration of the spleen.
Although the spleen is generally
involved in the presentation of the
leukaemia, splenectomy had little effect
upon the incidence or induction time of
MNIU induced leukaemias, similar to
methyleholanthrene induced leukaemia
in DBA mice (Law and Miller, 1950)
and x-ray induced lymphoid leukaemia in
RF mice (Upton et al., 1958). This may
mean that splenectomy does not perma-
nently affect the number of " target
cells " available for leukaemic transfor-
mation.
Leukaemias arising in thymectomized
MNU treated mice seem distinct from
those appearing in " intact " or splenec-
tomized mice in that they have a prolonged
induction time and are characterized by a
high number of animals presenting with
mesenteric lymph node involvement. The
reported effect of thymectomy on the
incidence of lymphoid leukaemia is vari-
able, in some cases causing a pronounced
reduction in the incidence of leukaemia
(Kaplan, Brown and Paull, 1953; Law
and Miller, 1950; Peled and Haran-Ghera,
1971), in others having little effect either
on the induction times or the incidence of
leukaemia (Haran-Ghera and Peled, 1973).
The variable effect of thymectomy upon
the incidence of leukaemia produced in
mice by different treatments may depend
upon " target " specificity of the leukae-
mogen. Adult thymectomy prevents
further processing of pre-T cells to T cells
andleadsto an impairment ofcell mediated
immunity in old age. If the initial target
cell for leukaemogenesis were the pre-T
(or an earlier precursor cell) which had
subsequently to be processed by the thy-
mus before leukaemic change became
apparent, then thymectomy would be
expected to have an inhibitory effect on
leukaemia development. However, it
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would have little influence on the induc-
tion of a leukaemia involving only B
lymphocytes. This was indeed found to
be the case in DMBA induced leukaemia
in SJL/J mice where leukaemia involved
B lymphocytes and its incidence was
essentially similar in intact, thymec-
tomized or T lymphocyte deficient mice
(Haran-Ghera and Peled, 1973). In our
experiments, whilst thymectomy alone
reduced the incidence somewhat and
prolonged the latent period, it did not
prevent leukaemias from developing.
However, in T lymphocyte deficient
(thymectomized, irradiated, bone marrow
reconstituted) mice, with a " normal "
complement of B cells, leukaemias did
not develop following MIN{J treatment.
Furthermore, our failure to induce signifi-
cant levels of leukaemia in potentially
lethally irradiated mice (where the thymus
architecture is available for the processing
of pre-T cells and as a site for leukaemia
development) or in potentially lethally
irradiated thymectomized mice (not able
to process pre-T cells) by reconstituting
them with MNUJ treated bone marrow
(either 1 day or 70 days post MNU
treatment) suggests that concomitant
with the absence of MNU treated T lym-
phocytes, the target cells have also been
lost. This would imply that the haemo-
poietic stem cells andpre-Tcellsinjectedare
not the " MNU leukaemia " inducing cells,
and that the likely target cell for MNU
leukaemia is the T lymphocyte (which
would not be expected to be present in
significant numbers in the injected bone
marrow). The initial studies with cell
surface markers, showingauniformabsence
of B lymphocyte surface markers in
leukaemic tissue and the general suscepti-
bility ofthe leukaemic cells to cytotoxic 0
antiserum, are in keeping with such a
hypothesis. The low anti-O cytotoxic
indices in the spleens of leukaemic mice
showing no thymus involvement (Group
D, Table III) and the concomitant
absence of surface Ig could at this stage
be taken to implicate also a pre-T or
even a non-T type of cell, or simply
" masking " of the expression of antigens
on the leukaemic cells. There are, how-
ever, no indications that this would
belong to the B cell differentiation path-
way, since even in thymectomized mice
the leukaemias arising after MN(U treat-
ment do not carry Ig surface markers,
but do express 0 antigen.
Whether the inability to induce B
lymphocyte leukaemias after MNU (com-
pared with DMBA) is due to mouse strain
differences or to differences in the mech-
anism of action of various chemical
leukaemogens will have to be elucidated.
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